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Synopsis11
Olivetolic acid cyclase (OAC) from Cannabis sativa L. has been overexpressed in E. coli, purified, and crystal-12
lized. Diffraction data have been collected to a resolution of 1.40 Å. 13
Abstract14
Plant polyketides are a structurally diverse family of natural products. In the biosynthesis of plant polyketides, the con-15
struction of the carbocyclic scaffolds is a key step for diversifying the polyketide structure. Olivetolic acid cyclase (OAC) 16
from Cannabis sativa L. is the only known plant polyketide cyclase that catalyzes the C2/C7 intramolecular aldol cycliza-17
tion of linear pentyl tetra-β-ketide CoA to generate olivetolic acid in the biosynthesis of cannabinoid. The enzyme is also 18
thought to belong to the dimeric α+β barrel (DABB) protein family. However, because of lack of the functional analysis 19
of the other plant DABB proteins and low sequence identity with the functionally and structually characterized bacterial 20
DABB proteins, the catalytic mechanism of OAC has remained unclear. To clarify the intimate catalytic mechanism of 21
OAC, the enzyme was overexpressed in Escherichia coli and crystallized in a vapour-diffusion method. The crystals 22
diffracted X-rays to 1.40 Å resolutions and belonged to space group P3121 or P3221, with unit-cell parameters a = b = 23
47.3 Å, c = 176.0 Å. Further crystallographic analysis will provide valuable insights into the structure–function relation-24
ship and catalytic mechanism of OAC. 25
1. Introduction26
Plant polyketides, such as flavonoids, stilbenes, and phloroglucinols, are one of the largest and most important families 27
of natural products, with remarkable structural diversity and biological activities. In the biosynthesis of plant 28
polyketides, the construction of the carbocyclic scaffolds is a key step for diversifying the polyketide structures. This 29
process is generally catalyzed by a type III polyketide synthase (PKS), by carbon chain elongation and subsequent 30
cyclization of the highly reactive poly-β-keto intermediate (Schröder, 1999; Austin & Noel, 2003; Abe & Morita, 2010). 31
Recent studies have suggested that the biosyntheses of plant polyketides, such as the anthranoid (Abe et al., 2005; Abdel-32
Rahman et al., 2013) and cannabinoid (Taura et al., 2009; Gagne et al., 2012), produced by Aloe arborescens  33
and Cannabis sativa, respectively, require additional enzymes for proper folding cyclization of the linear poly-β-34
keto intermediate to generate the final products, as in the cases of bacterial polyketide biosyntheses. 35
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 The recently identified olivetolic acid cyclase (OAC) from C. sativa is a novel polyketide cyclase that is proposed 36
to be involved in the biosynthesis of cannabinoid. The enzyme is the only known plant polyketide cyclase, and is thought 37
to accept the linear pentyl tetra-β-ketide CoA, produced by a type-III PKS tetraketide synthase (TKS), as the substrate, 38
and perform the C2–C7 aldol cyclization, thioester bond cleavage, and aromatization reactions to generate olivetolic 39
acid (OA), without requiring any co-factors (Fig. 1, Gagne et al., 2012). OAC shares 30-48% identity with 40
functionally unidentified plant dimeric α+β barrel (DABB) proteins, such as the structurally characterized heat stable pro-41
tein (AtHS1) from Arabidopsis thaliana  (48% identity, Bingman et al., 2004; Lytle et al., 2004), boiling stable protein 42
(SP1) from Populus tremula  (38% identity, Dgany et al., 2004), and At5g22580 from A. thaliana  (32% identity, 43
Cornilescu et al., 2004). OAC also shares low sequence identity (less than 20%) with bacterial DABB proteins, such as 44
the structurally characterized bacterial polyketide cyclase, tetracenomycin F2 cyclase (Tcm I) from Streptomyces 45
glaucescens  (17% identity, Thompson et al., 2004), and the functionally distinct, structurally characterized ActVA-Orf6 46
monooxygenase from S. coelicolor  (15% identity, Sciara et al., 2003) and 4-methylmuconolactone methylisomerase 47
(MLMI) from Pseudomonas reinekei  (13% identity, Marin et al., 2009). 48
 On the basis of these findings and a comparison of the homology model of OAC with the three-dimensional 49
structures of the plant and bacterial DABB proteins, OAC has been proposed to be a homodimeric protein consisting of 50
12.2 kDa subunits and to possess a hydrophobic tunnel as the active site cavity in each monomer (Gagne et al., 2012), as 51
in the cases of the other structurally characterized DABB proteins. Furthermore, site-directed mutagenesis studies have 52
suggested that three His residues (His5, His57, and His78) play crucial roles in the OA-forming activity (Gagne et al., 53
2012). However, the catalytic mechanism underlying the substrate and product specificities, the aldol cyclization and 54
aromatization reactions, and the thioester bond cleavage, as well as the catalytic role of the three His residues in the OA-55
forming activity, have remained unclear. Therefore, to further clarify the intimate structural details of the OAC catalyzed 56
reaction, we expressed glutathione S-transferase (GST)-fused recombinant OAC in Escherichia coli,  removed the GST 57
portion, and obtained good-quality crystals of the recombinant OAC.58
2. Materials and methods59
2.1. Expression and purification         60
The cDNA encoding full-length OAC, with SmaI/SalI sites just before the initiation codon and after the stop 61
codon, respectively, was purchased from Eurofins Genomics (Table 1). The cDNA was digested with SmaI/SalI and was 62
ligated into the SmaI/SalI sites of the modified pQE-80L vector (QIAGEN), for expression as a fusion protein with GST 63
at the N-terminus. A PreScission Protease (GE Healthcare) cleavage site was introduced between GST and OAC. The 64
constructed expression plasmid was transformed into E. coli M15 cells (QIAGEN), and the cells harboring the plasmid 65
were cultured to an OD600 of 0.6 in Luria broth (LB) medium, containing 100 μg ml-1 ampicillin, at 310 K. Isopropyl β-66
D-1-thiogalactopyranoside was added to a final concentration of 1 mM to induce protein expression, and the culture 67
was incubated at 290 K for a further 20 h. 68
 All of the following procedures were performed at 277 K. The E. coli cells were harvested by centrifugation at 5,000 69
g for 20 min, and then resuspended in 50 mM Tris-HCl buffer, pH 8.0, containing 200 mM NaCl, 5%(v/v) glycerol and 70
2 mM DTT (buffer A). The cells were disrupted by sonication, and the lysate was centrifuged at 6,000 g for 10 min. The 71
supernatant was loaded on a COSMOGEL GST-Accept Resin column (Nacalai Tesque) equilibrated with buffer A. After 72
the column was washed with 20 mM HEPES-NaOH buffer, pH 7.5, containing 100 mM NaCl, 5%(v/v) glycerol and 2 73
mM DTT (buffer B), the GST-tag was cleaved on the column by PreScission Protease (GE Healthcare) overnight, and 74
OAC was eluted with buffer B. The resultant protein thus contains three additional N-terminal residues (GPG), derived 75
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from the PreScission Protease recognition sequence. The protein solution was diluted ten-fold with 20 mM HEPES-76
NaOH buffer, pH 7.5, containing 2 mM DTT (buffer C), and then applied to a Resource Q column (GE Healthcare). The 77
column was washed with buffer C containing 10 mM NaCl, and the protein was subsequently eluted at 50 mM NaCl, 78
using a linear gradient of 10-200 mM NaCl. The protein was further purified by size-exclusion chromatography on a 79
HiLoad 16/60 Superdex 200 prep grade column (GE Healthcare), and was concentrated to 17 mg ml-1 in 20 mM HEPES-80
NaOH buffer,  pH 7.5, containing 25 mM NaCl.81
 A dynamic light-scattering (DLS) analysis was performed, using a DynaPro-MSXTC molecular-sizing 82
instrument (Protein Solutions). After centrifugation through a 0.22 µm Ultrafree-MC filter (Millipore) to remove partic-83
ulate material from the protein solution, the solution properties of the purified protein were monitored. Data were ac-84
quired as 50 scattering measurements at 293 K. Data from five sets of measurements were analyzed using the 85
DYNAMICS software  package (Protein Solutions) and averaged.86
2.2. Crystallization87
Initial crystallization conditions were found by screening with the commercial JCSG+ Suite screening kit 88
(QIAGEN). The crystallizations were performed at 278 K, using the sitting-drop vapour-diffusion method with a 96-well 89
plate. All crystallization drops were prepared by mixing 1 µl of protein solution (17 mg ml-1) with an equal volume of 90
reservoir solution, and were equilibrated against 50 μl reservoir solution. Clusters of crystals were observed three days 91
later, in the crystallization condition consisting of 100 mM Bicine, pH 8.5, and 20%(w/v) PEG 6000. Further 92
crystallization was attempted using Additive Screen HT (Hampton Research) at various pH values, together with the use 93
of 20%–30%(w/v) PEG 6000 as a precipitant. Diffraction-quality crystals were finally obtained at 278 K, in 100 94
mM Tris-HCl, pH 8.8, 25%(w/v) PEG 6000, and 100 mM sodium malonate, using the sitting-drop vapour-diffusion 95
method (Table 2).96
2.3. Data collection and processing97
Single crystals were transferred into a crystallization solution containing 10%(v/v) glycerol as a cryoprotectant, picked up 98
with a nylon loop, and then flash-cooled at 100 K in a nitrogen-gas stream. X-ray diffraction data sets were collected on 99
Beamline NW-12A at the Photon Factory (PF; wavelength 1.0000 Å) using an ADSC Q210r detector, with a distance of 100
117.1 mm between the crystal and the detector. A total of 360 frames were recorded, with a 0.5º oscillation angle and 1 s 101
exposure time. The data were indexed, integrated, and scaled with the XDS program package (Kabsch, 2010). 102
The Matthews volume (VM) and the solvent content were calculated with Xtriage (Adams et al., 2010).103
3. Results and discussion104
The recombinant OAC was overexpressed in E. coli, as a fusion protein with a GST-tag at the N-terminus. After 105
cleavage of the GST-tag, the purified OAC migrated as a single band with a molecular weight of 10 kDa upon 20%(w/v) 106
SDS-PAGE, in agreement with the calculated molecular weight of 12.2 kDa (Fig. 2a). In contrast, the gel-filtration 107
experiment by size exclusion chromatography indicated a molecular weight of 25 kDa (Fig. 2b). In addition to the gel-108
filtration analysis, the DLS analysis after the size-exclusion chromatography revealed a monomodal distribution, with a 109
polydispersity value of 9.5% and a molecular weight estimate of 23 kDa, which allowed us to confirm that the 110
recombinant OAC is a homodimeric protein, and also suggested that OAC is a member of the DABB protein family. The 111
typical yield of the purified recombinant OAC was about 1.5 mg per liter of culture. 112
 The OAC crystals appeared reproducibly in the optimized crystallization solution within a few days, with various 113
sizes up to approximate dimensions of 0.15 × 0.15 × 0.12 mm. Among them, only the crystals with approximate dimen-114
sions of 0.07 × 0.07 × 0.06 mm gave good quality diffraction up to 1.40 Å resolution (Fig. 3). The detailed data collection 115
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statistics are summarized in Table 3. The preliminary crystallographic analysis indicated that the crystals belonged to the 116
space group P3121 or P3221, with unit-cell parameters a = b = 47.3 Å, c = 176.0 Å. With two monomers in the asymmet-117
ric unit, the Matthews volume (VM) was calculated to be 2.5 Å3 Da-1  and the estimated solvent content was 50.7%, which 118
is in the range normally observed for protein crystals. Structure determination by the molecular-replacement method is 119
currently under way, using the Phaser (McCoy et al., 2007) and Molrep (Vagin & Teplyakov, 2010) programs with the 120
crystal structures of the plant DABB proteins, AtHS1 (PDB entry 1q53), At5g22580 (PDB entry 1rjj), and SP1 (PDB 121
entry 1si9), and the other bacterial homologues, such as TcmI (PDB entry 1tuw), ActVA-Orf6 (PDB entry 1lq9), and 122
MLMI (PDB entry 2ifx) as search models. Simultaneously, we are also attempting to crystallize OAC complexed with its 123
product and product analogues, together with the expression, purification, and crystallization of selenomethionine-labeled 124
OAC. These structural analyses will provide valuable insights into not only the structure–function relationship and 125
catalytic mechanism of OAC, but also the functional diversity of the DABB proteins.126
Table 1127
Macromolecule production information 128
129 Source organism Cannabis sativa L.
130 DNA source Chemical synthesis
131 Cloning vector pEX-A
132 Expression vector pQE-80L
133 Expression host M15 (QIAGEN)








†The amino-acid sequence of glutathione S-transferase (GST) tag is shown in italics. PreScision protease recognition site (LEVLFQGP) is underlined. The 135
peptide bond between the Q and G residues is cleaved by PreScision protease.136
Table 2137
Crystallization 138
139 Method sitting-drop vapour-diffusion method
140 Plate type 96 well CrystalQuick, 288 square wells, flat bottom (greiner bio-one)
141 Temperature (K) 278
142 Protein concentration 17 mg ml-1
143 Buffer composition of protein solution 20 mM HEPES-NaOH buffer, pH 7.5, and 25 mM NaCl
144 Composition of reservoir solution 100 mM Tris-HCl, pH 8.8, 25%(w/v) PEG 6000, and 100 mM sodium malonate
145 Volume and ratio of drop (µl) 1:1
146 Volume of reservoir (µl) 50
Table 3147
Data collection and processing148
Values for the outer shell are given in parentheses. 149
150 Diffraction source NW-12A, PF
151 Wavelength (Å) 1.0000
152 Temperature (K) 100
153 Detector ADSC Q210r
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154 Crystal-detector distance (mm) 117.1
155 Rotation range per image (°) 0.5
156 Total rotation range (°) 180
157 Exposure time per image (s) 1
158 Space group P3121 or P3221
159 a, b, c (Å) 47.3, 47.3, 176.0
160 Mosaicity (°) 0.193
161 Resolution range (Å) 50.0 - 1.40 (1.48 - 1.40)
162 Total No. of reflections 475,525 (74,586)
163 No. of unique reflections 45,736 (7,287)
164 Completeness (%) 98.9 (98.9)
165 Redundancy 10.4 (10.2)
166 〈 I/σ(I)〉 24.2 (12.3)
167 Rmerge 0.074 (0.155)
168 Overall B factor from Wilson plot (Å2) 10.19
169 No. molecules per AU 2
170 VM (Å3 Da-1) 2.5
171 Vsolv (%) 50.7
 , where I(hkl) is the intensity of reflection hkl,   is the sum over all 172
reflections, and   is the sum over i measurements of reflection hkl.173
/Local/Ix86/Linux/httpd/htdocs/pubcryst/publusers/c40783c2-d600-6324-b991-475435e2ba99/new_1/1441256749049_original.jpg
Figure 1 ↶ 174
Proposed mechanism for the formation of olivetolic acid by OAC.175
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Figure 2 ↶ 176
Analysis of molecular weight of OAC. (a) SDS-PAGE gel is shown. Lane 1, molecular weight marker; lane 2, peak 177
fraction. Molecular weight markers are labelled in kDa. (b) Chromatogram of size-exclusion chromatography is shown. 178




Figure 3 ↶ 180
Crystals of OAC. The dimensions of the crystals were approximately 0.07 × 0.07 × 0.06 mm.181
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